… response in asymptomatic left ventricular dysfunction (LVD), the … heart failure, the diagnostic
and prognostic significance of the natriuretic peptides in CHF, and the therapeutic potential …

… in the action potential, in angiogenesis … diagnostic role in heart failure and modification of
specific microRNAs levels has been tested as a therapeutic option in experimental heart failure …

… certain conditions of coronary heart disease, congestive heart failure, and atherosclerosis,
as well as in systemic and pulmonary hypertension, cirrhosis and of chronic renal failure. The …

… used) to aid in the accurate diagnosis of heart failure in patients admitted to the emergency
room with symptoms of decompensated heart failure. Furthermore, circulatory BNP has been …

… development of chronic heart failure. This review discusses the potential of transforming growth
… 2 (ST2) to become additional heart failure markers which will lead to the improvement of …

… We review the current state of microRNAs as biomarkers of heart failure and associated …
specific microRNAs may be targeted with novel therapeutics designed to treat heart failure. …

… Although iron should be given to patients with heart failure and iron deficiency, sufficient
consideration should be given to the route of administration and the potential for adverse effects…

… In cardiovascular disease pathophysiology, there are several cells that produce microRNAs,
including endothelial cells, vascular smooth muscle cells, macrophages, platelets, and …

… Heart failure (HF), as the leading cause of death, is continuing to increase along with the …
potentials for diagnosis and prognosis of HF patients, and in association with therapeutic effects …

… , we review potential future therapies for CHF, … therapeutic interventions. The focus is on
ambulatory CHF associated with left ventricular (LV) systolic dysfunction, although heart failure …